Dynamics of the Indicators of Lung Destruction and Hormonal Background as a Predictive Marker of the Effectiveness of Multidrug Resistant Tuberculosis Treatment

Avicenna Bulletin
doi 10.25005/2074-0581-2019-21-1-110-115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Avicenna Tajik State Medical University

Related search

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Comparison of the Validity of Smear and Culture Conversion as a Prognostic Marker of Treatment Outcome in Patients With Multidrug-Resistant Tuberculosis

PLoS ONE
Multidisciplinary
2018English

Is Bedaquiline as Effective as Fluoroquinolones in the Treatment of Multidrug-Resistant Tuberculosis?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Reducing Harm in the Treatment of Multidrug-Resistant Tuberculosis

The Lancet
Medicine
2018English

Rifabutin: Is It Useful in the Treatment of Multidrug-Resistant Tuberculosis?

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Bedaquiline: New Approach for Treatment of Multidrug-Resistant Tuberculosis

RUHS Journal of Health Science
2019English

Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2013English

Therapeutic Drug Management: Is It the Future of Multidrug-Resistant Tuberculosis Treatment?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

P56 Treatment of Multidrug Resistant Tuberculosis: Where Are the Guidelines for Monitoring?

Thorax
PulmonaryRespiratory Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy